Jiangsu Nanfang Medical Hits Day High with 8.15% Surge in Stock Price

Jiangsu Nanfang Medical Co., Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 8.15% as of May 22, 2026. The stock reached an intraday high of CNY 8.91, reflecting a robust performance compared to the China Shanghai Composite, which only increased by 0.87% on the same day. Over the past week, Jiangsu Nanfang Medical has outperformed the broader market with a 2.1% increase, while the Shanghai Composite declined by 0.54%. The company's one-month performance stands at an impressive 37.09%, significantly higher than the composite's modest 0.16% gain. Year-to-date, Jiangsu Nanfang Medical has achieved a remarkable 40.61% increase, compared to the Shanghai Composite's 3.63%. In terms of longer-term performance, Jiangsu Nanfang Medical has seen a substantial 63.74% rise over the past year and an impressive 102.78% increase over the last three years. Despite these gains, the company is currently loss-making, with a return on equity of -57.03% and a debt-to-equity ratio of 2.25.